BIOHARVEST SCIENCES INC.BHSTEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
BioHarvest Sciences Inc. is a biotechnology firm that develops and produces sustainable, high-purity plant-derived bioactive ingredients. It serves the nutraceutical, cosmetics, and pharmaceutical sectors, leveraging proprietary cell cultivation technology to create efficacious natural products without large-scale agricultural farming.
BHST Q3 FY2025 Key Financial Metrics
Revenue
$8.4M
Gross Profit
$5.1M
Operating Profit
N/A
Net Profit
N/A
Gross Margin
60.3%
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
BIOHARVEST SCIENCES INC. Q3 FY2025 Financial Summary
BIOHARVEST SCIENCES INC. reported revenue of $8.4M for Q3 FY2025, with a net profit of N/A (N/A margin). Cost of goods sold was $3.3M.
Key Financial Metrics
| Total Revenue | $8.4M |
|---|---|
| Net Profit | N/A |
| Gross Margin | 60.3% |
| Operating Margin | N/A |
| Report Period | Q3 FY2025 |
BIOHARVEST SCIENCES INC. Quarterly Revenue & Net Profit History
BIOHARVEST SCIENCES INC. results over the last 5 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 FY2025 | $8.4M | — | N/A | N/A |
| Q2 FY2025 | $8.1M | — | N/A | N/A |
| Q1 FY2025 | $7.7M | — | N/A | N/A |
| Q3 FY2024 | $6.5M | — | N/A | N/A |
| Q2 FY2024 | $6.0M | — | N/A | N/A |
Income Statement
| Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|
| Revenue | $6.0M | $6.5M | $7.7M | $8.1M | $8.4M |
| YoY Growth | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|
| Assets | N/A | N/A | N/A | N/A | N/A |
| Liabilities | N/A | N/A | N/A | N/A | N/A |
| Equity | N/A | N/A | N/A | N/A | N/A |
Cash Flow
No data available for this period